Ingredient or product comparison
GHK-Cu Post-Surgery Healing Research: Comparison of Application Methods
Topical cream (2–5 μM) Moderate. Depends on wound depth and vehicle penetration Twice daily for 7–10 days Strong. Multiple RCTs show efficacy Best for superficial surgical wounds (dermabrasion, excision, laser) where direct application reaches target tissue Su
This source-based comparison does not add ratings or recommend a winner.
- Topical cream (2–5 μM)
- Moderate. Depends on wound depth and vehicle penetration
- Twice daily for 7–10 days
- Strong. Multiple RCTs show efficacy
- Best for superficial surgical wounds (dermabrasion, excision, laser) where direct application reaches target tissue
- Subcutaneous injection (0.5–2 mg)
- High. Peptide delivered directly to deeper tissue layers
- Once daily for 5–7 days
- Moderate. Case series and observational data, no large RCTs
- Appropriate for deep surgical sites (joint repair, tendon surgery) where topical penetration is insufficient
- Hydrogel dressing (sustained release)
- High. Maintains stable concentration over 24–48 hours
- Dressing change every 48 hours
- Emerging. Early-phase trials show promise
- Ideal for wounds requiring occlusive dressing and prolonged peptide exposure (burns, large excisions)
- Oral supplementation
- Very low. Peptide degraded in GI tract before systemic absorption
- Not applicable
- Insufficient. No peer-reviewed evidence
- Not recommended. GHK-Cu requires localized delivery to be effective
- The hydrogel method is gaining traction in clinical settings because it solves the compliance problem. Patients don't need to remember twice-daily application, and the peptide remains in contact with the wound continuously. A 2023 pilot study from the University of Miami used GHK-Cu-loaded hydrogel on post-mastectomy patients and reported 28% reduction in delayed wound healing compared to standard silicone dressings.